Emilio Medina Rivero
About Emilio Medina Rivero
Emilio Medina Rivero serves as the Subdirector de Nuevos Desarrollos at Landsteiner Scientific since 2021, bringing extensive experience in biopharmaceutical development and regulatory documentation. He has a strong academic background with a PhD in Molecular Biology and has authored 51 research papers, contributing significantly to the field.
Current Role at Landsteiner Scientific
Emilio Medina Rivero serves as Subdirector de Nuevos Desarrollos at Landsteiner Scientific since 2021. In this role, he focuses on the development of new projects and initiatives within the organization. His responsibilities include overseeing various aspects of project management and ensuring alignment with the company's strategic objectives.
Previous Experience at Probiomed S.A. de C.V.
Emilio worked at Probiomed S.A. de C.V. for a total of nine years, holding two key positions. He served as Principal Scientist from 2008 to 2016, where he contributed significantly to research and development. Prior to that, he was an Associate Scientist in Protein Analytical Chemistry from 2007 to 2008, focusing on protein analysis and characterization.
Technical-Scientific Leadership at UDIBI
From 2016 to 2020, Emilio held the position of Technical-Scientific Director at UDIBI in Ciudad de México. In this role, he was responsible for leading scientific initiatives and managing technical teams. His leadership contributed to the advancement of various projects within the organization.
Educational Background and Research Experience
Emilio's educational journey includes a BSc in Biochemical Engineering from Instituto Tecnológico de Mérida, ITM, and an MSc in Biotechnology from Universidad Autónoma Metropolitana, UAM-I. He also earned a PhD in Molecular Biology from the Institute for Scientific and Technological Research of San Luis Potosi, IPICYT. Additionally, he completed a Research Stay at the University of Illinois at Urbana-Champaign in 2005, enhancing his research capabilities.
Publications and Patents
Emilio has published 51 research papers, reflecting his active engagement in scientific research and contribution to the field. He has also invented patents, showcasing his innovative approach and contributions to intellectual property within the biopharmaceutical sector. His expertise extends to designing biopharmaceutical dossiers, indicating a strong understanding of regulatory requirements.